SLC1A5 and neoplasm: In conclusion, circ_0025033 interference repressed ovarian cancer cell malignant behaviors and glutamine metabolism via the hsa_miR-370-3p/SLC1A5 axis, indicating an underlying therapeutic target for the tumor.